Candidate autoantigens in multiple sclerosis

Multiple Sclerosis

Volumn 5, Issue 3, 1999, Pages 147-160

  Schmidt, Stephan ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Autoantigens; B cells; Multiple sclerosis; Myelin; T cells

Indexed keywords

ANTIBODY; AUTOANTIGEN; CRYSTALLIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; GLYCOPROTEIN; HEAT SHOCK PROTEIN; HLA DR ANTIGEN; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN; PROTEIN S 100; PROTEOLIPID PROTEIN; TRANSALDOLASE; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM DISEASE; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; ISOMER; MEASLES VIRUS; MOLECULAR BIOLOGY; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; ORAL DRUG ADMINISTRATION; T LYMPHOCYTE; TISSUE DISTRIBUTION;

EID: 0033031926     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500303     Document Type: Article

References (163)

1. Lassman H. (1983) Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer-Verlag: Berlin.
2. Lassman H, Vass K. (1995) Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions? Springer Semin Immunopathol 17: 77-87.
3. Lucchinetti CF, Brück W, Rodriguez M, Lassman H. (1996) Distinct patterns of Multiple Sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6: 259-274.
4. Berger T et al. (1997) Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76: 355-364.
5. Bradl M, Linington C. (1996) Animal models of demyelination. Brain Pathol 6: 303-311.
6. Wekerle H et al. (1994) Animal Models. Ann Neurol 36: S47-S53.
7. Brosnan CF, Raine CS. (1996) Mechanisms of immune injury in Multiple Sclerosis. Brain Pathol 6: 243-257.
8. Hohlfeld R et al. (1995) The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology 45 (Suppl.6): S33-S38.
9. Martin R, McFarland HF, McFarlin DE. (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153-187.
10. Martin R, McFarland HF. (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32: 121-182
11. Kojima K et al. (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J Exp Med 180: 817-829.
12. Kojima K et al. (1997) The thymus and self-tolerance: co-existence of encephalitogenic S100 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus. Int Immunol 9: 897-904.
13. Kojima K et al. (1997) Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. J Neural Transm 49 (Suppl.): 43-51.
14. Segal BM et al. (1994) Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination. J Neuroimmunol 51: 7-19.
15. Chou YK et al. (1992) Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in Multiple sclerosis. J Neuroimmunol 38: 105-114.
16. Kerlero de Rosbo N et al. (1993) Reactivity to myelin antigens in Multiple sclerosis. Peripheral blood lymphocytes respond to predominantly myelin oligodendrocyte glycoprotein. J Clin Invest 92: 2602-2608.
17. Lindert RB, Linington C, Wekerle H, Hohlfeld R. (1998) Characterization of myelin oligodendrocyte glycoprotein (MOG)-specific T cell lines from Multiple Sclerosis patients and healthy donors. Neurology 50 (suppl.4): A359-A360.
18. Markovic-Plese S et al. (1995) T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J Immunol 155: 982-992.
19. Meinl E et al. (1993) Myelin basic protein-specific T lymphocyte repertoire in Multiple Sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 92: 2633-2643.
20. Pelfrey CM, Trotter JL, Tranquill LR, McFarland HF. (1993) Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J Neuroimmunol 46: 33-42.
21. Pelfrey CM, Tranquill LR, Vogt AB, McFarland HF. (1996) T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls. Mult Scler 1: 270-278.
22. Pette M et al. (1990a) Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770-1776.
23. Pette M et al. (1990b) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci 87: 7968-7972.
24. Schmidt S et al. (1997) Multiple Sclerosis: Comparison of the human T cell response to S100β and MBP reveals parallels to rat experimental autoimmune panencephalitis (EAP). Brain 120: 1437-1445.
25. Zhang Y et al. (1993) The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis. Neurology 43: 403-407.
26. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. (1990) T cells responsive to myelin basic protein in patients with Multiple Sclerosis. Science 247: 718-721.
27. Link H et al. (1992) Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 38: 63-74.
28. Lodge PA, Allegretta M, Steinman L, Sriram S. (1994) MBP peptide specificity and TCR gene usage of hprt mutant T cell clones in patients with Multiple Sclerosis. J Immunol 36: 734-740.
29. Lu CZ, Frederikson S, Xiao BG, Link H. (1993) Interleukin-2 secreting cells in multiple sclerosis and controls. J Neurol Sci 120: 99-106.
30. Olsson T et al. (1990) Autoreactive T lymphocytes in Multiple Sclerosis determined by antigen-induced secretion of interferon-γ. J Clin Invest 86: 981-985.
31. Sriram S. (1994) Longitudinal study of frequency of HRPT mutant T cells in patients with multiple sclerosis. Neurology 44: 311-315.
32. Sun JB et al. (1991) Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 21: 1461-1468.
33. Sun JB et al. (1991) T and B cell responses to myelin-oligodendrocyte glycoprotein in Multiple Sclerosis. J Immunol 146: 1490-1495.
34. Trotter JL et al. (1997) HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin protelipid protein peptides. J Neuroimmunol 75: 95-103.
35. Zhang J et al. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with Multiple Sclerosis. J Exp Med 179: 973-984.
36. Cuzner ML, Norton WT. (1996) Biochemistry of demyelination. Brain Pathol 6: 231-242.
37. Norton WT, Cammer W. (1984) Isolation and characterization of myelin. In: Morell P (ed). Myelin. Plenum: New York: pp 147-180.
38. Deibler GE, Burlin TV, Stone AL. (1995) Three isoforms of human myelin basic protein: purification and structure. J Neurosci Res 41: 819-827.
39. Kamholz J, Toffenetti J, Lazzarini RA. (1988) Organization and expression of the human myelin basic protein gene. J Neurosci Res 21: 62-70.
40. Jordan CA et al. (1990) Differential exon expression in myelin basic protein transcripts during central nervous system (CNS) remyelination. Cell Mol Neurobiol 10: 3-18.
41. Shiota C, Miura M, Mikoshiba K. (1989) Developmental profile and differential localization of mRNAs of myelin basic protein (MBP and PLP) in oligodendrocytes in the brain and in culture. Brain Res Dev Brain Res 45: 83-94.
42. Moscarello MA. Myelin basic protein: a dynamically changing structure. In: Hashim GA, Moscarello M (eds). (1990) Dynamic interactions of myelin proteins. Wiley: New York: pp 25-48.
43. Moscarello MA, Wood DD, Ackerley CA, Boulias CA. (1994) Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94: 146-154.
44. Campagnoni AT et al. (1993) Structure and developmental regulation of Golli-MBP, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem 268: 4930-4938.
45. Pribyl TM et al. (1996) Expression of the myelin basic protein gene locus in neurons and oligodendrocytes in the human fetal central nervous system. J Comp Neurol 374: 342-353.
46. Pribyl TM et al. (1993) The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci 90: 10695-10699.
47. Genain CP, Hauser SL. (1997) Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 75: 187-197.
48. Meinl E et al. (1997) Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am J Pathol 150: 445-453.
49. Wucherpfennig KW, Weiner HL, Hafler DA. (1991) T-cell recognition of myelin basic protein. Immunol Today 12: 277-282.
50. Joshi N, Usuku K, Hauser SL. (1993) The T cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements and T cell receptor usage. Ann Neurol 34: 385-393.
51. Wucherpfennig KW et al. (1994) Clonal expression and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 152: 5581-5592.
52. Ota K et al. (1990) T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183-187.
53. Shanmugam A et al. (1995) In vivo clonal expansion of T lymphocyte specific for an immunodominant N-terminal myelin basic protein epitope in healthy individuals. J Neuroimmunol 59: 165-172.
54. Muraro PA et al. (1997) Immunodominance of a low affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest 100: 339-349.
55. Valli A et al. (1993) Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 91: 616-628.
56. Vogt AB et al. (1994) Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 153: 1665-1673.
57. Martin R et al. (1991) A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with Multiple Sclerosis. J Exp Med 173: 19-24.
58. Allegrotta M et al. (1994) Homologies between T cell receptor junctional sequence unique to Multiple Sclerosis and T cells mediating experimental allergic encephalomyelitis. J Clin Invest 94: 105-109.
59. Kotzin BL et al. (1991) Preferential T cell receptor β-chain variable gene use in myelin basic protein-reactive T cell clones from patients with multiple sclerosis. Proc Natl Acad Sci 88: 9161-9165.
60. Wucherpfennig K et al. (1990) Shared human T cell receptor Vβ usage to immunodominant regions of myelinn basic protein. Science 248: 1016-1019.
61. Gold DP et al. (1997) Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. J Neuroimmunol 76: 29-38.
62. Lee SJ et al. (1991) Common T-cell receptor Vβ usage in oligoclonal T lymphocytes derived from cerebrospinal and blood of patients with multiple sclerosis. Ann Neurol 29: 33-40.
63. Hafler DA et al. (1996) TCR usage in human and experimental demyelinating disease. Immunol Today 17: 152-159.
64. Vandevyver C et al. (1995) Clonal expansion of myelin basic protein-reactive T cells in patients with Multiple Sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 25: 958-968.
65. Warren KG, Catz I, Johnson E, Mielke B. (1994) Antimyelin basic protein and anti-proteolipid protein specific forms of Multiple Sclerosis. Ann Neurol 35: 280-289.
66. Wucherpfennig KW et al. (1997) Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest 100: 1114-1122.
67. Critchfield JM et al. (1994) T cell deletion in high dose therapy of autoimmune encephalomyelitis. Science 263: 1139-1143.
68. Racke MK et al. (1996) Intravenous antigen administration as a therapy for autoimmune demyelinating diseases. Ann Neurol 39: 46-56.
69. 96 in chronic progressive multiple sclerosis. J Neurol Sci 152: 31-38.
70. Wood DD, Moscarello MA. (1989) The isolation, characterization, and lipid-aggregating properties of a citrulline-containing myelin basic protein. J Biol Chem 264: 5121-5127.
71. Fannon AM, Moscarello MA. (1990) Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse. Biochem J 268: 105-110.
72. Deber CM et al. (1986) Binding of human normal and multiple sclerosis-derived myelin basic protein to phospholipid vesicles: effects on membrane head group and bilayer regions. Arch Biochem Biophys 245: 455-463.
73. Wood DD, Bilbao JM, O'Connors P, Moscarello MA. (1996) Acute Multiple Sclerosis (Marburg Type) is associated with developmentally immature myelin basic protein. Ann Neurol 40: 18-24.
74. Martin R et al. (1994) Citrulline-containing myelin basic protein is recognized by T-cell lines derived from Multiple Sclerosis patients and healthy individuals. Neurology 44: 123-129.
75. Capello E, Voskuhl RR, McFarland HF, Raine CS. (1997) Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination. Ann Neurol 41: 797-805.
76. Voskuhl RR, McFarlin DE et al. (1993) A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to remyelination. J Neuroimmunol 46: 137-144.
77. Voskuhl RR et al. (1994) HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis. J Immunol 153: 4834-4844.
78. Nye SH et al. (1995) Purification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein. Mol Immunol 32: 1131-1141.
79. Tranquill LR et al. (1996) Human T lymphocytes specific for the immunodominant 83-99 myelin basic protein: recognition of golli MBP HOG7. J Neurosci Res 45: 820-828.
80. Hohlfeld R. (1997) Biotechnical agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120: 865-916.
81. Vergelli M et al. (1996) Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur J Immunol 26: 2624-2634.
82. Windhagen A et al. (1995) Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2: 373-380.
83. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H. (1988) Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332: 843-845.
84. Sun D, Ben-Nun A, Wekerle H. (1988) Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T line cells. Eur J Immunol 18: 1993-1999.
85. Zhang J et al. (1993) MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261: 1451-1454.
86. Zhang J, Vandevyver C, Stinissen P, Raus J. (1995) In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J Immunol 155: 5868-5877.
87. Oksenberg JR et al. (1993) Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362: 68-70.
88. Bourdette DN et al. (1994) Immunity to TCR peptides in Multiple Sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152: 2510-2519.
89. Chou YK et al. (1994) Immunity to TCR peptides in Multiple Sclerosis. II. T cell recognition of Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 152: 2520-2529.
90. Vandenbark AA et al. (1996) Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med 2: 1109-1115.
91. Zipp F et al. (1998) Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain 121 (in press).
92. Hafler DA, Weiner HL. (1995) Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev 144: 75-107.
93. Hafler DA, Weiner HL. (1995) Antigen-specific therapies for the treatment of autoimmune diseases. Springer Semin Immunopathol 17: 61-76.
94. Chen Y et al. (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
95. Weiner HL et al. (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
96. Kent SC et al. (1997) Oral administration of myelin induces antigen-specific TGF-beta 1-secreting T cells in Multiple Sclerosis patients. Ann NY Acad Sci 815: 412-422.
97. Stoffel W, Hillen H, Giersiefen H. (1984) Structure and molecular arrangement of proteolipid protein of central nervous system myelin. Proc Natl Acad Sci 81: 5012-5016.
98. Lees MB, Brostoff SW. (1984) Proteins of myelin. In: Morell P (ed). Myelin. 2nd edn. Plenum: New York: pp 197-217.
99. Correale J et al. (1995) Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 45: 1370-1378.
100. Greer JM et al. (1997) Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain 120: 1447-1460.
101. Quarles RH, Colman DR, Salzer JL, Trapp BD. (1992) Myelin-associated glycoprotein: Structure-function relationships and involvement in neurological diseases. In: Martenson (ed). Myelin: Biology and Chemistry. CRC Press: Boca Raton, Florida: pp 413-448.
102. Moller JR. (1996) Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates. Brain Res 71: 27-31.
103. Tsuchida T et al. (1994) Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci 91: 10859-10863.
104. Amiguet P, Gardinier MV, Zanetta JP, Mathieu JM. (1992) Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein (MOG). J Neurochem 58: 1676-1682.
105. Pham-Dinh D, Della Gaspera B, Kerlero de Rosbo N, Dautigny A. (1995) Structure of the human myelin-oligodendrocyte glycoprotein gene and multiple alternative spliced isoforms. Genomics 29: 345-352.
106. Birling MC, Roussel G, Nussbaum F, Nussbaum JL. (1993) Biochemical and immunohistochemial studies with specific polyclonal antibodies directed against bovine myelin/oligodendrocyte glycoprotein. Neurochem Res 18: 937-945.
107. Gardinier MV, Amiguet P, Linington C, Matthieu JM. (1992) Myelin/oligodendrocyte Glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 33: 177-187.
108. Ballenthin PA, Gardinier MV. (1996) Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not in mice. J Neurosci Res 46: 271-281.
109. Lassmann H, Brunner C, Bradl M, Linington C. (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566-576.
110. Linington C et al. (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443-454.
111. Linington C, Engelhardt B, Kapocs G, Lassman H. (1992) Induction of persistently domyelinating lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 40: 219-224.
112. Linington C et al. (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364-1372.
113. Mendel I, Kerlero de Rosbo N, Ben-Nun A. (1996) Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta and T cell receptor V beta in a H-2b mice. Eur J Immunol 26: 2470-2479.
114. Genain CP et al. (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274: 2054-2057.
115. Amor S et al. (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349-4356.
116. Johns TG et al. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling Multiple Sclerosis. J Immunol 154: 5536-5541.
117. Bernard CCA et al. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75: 77-88.
118. Ishikawa M, Johns TG, Liu J, Bernard CC. (1996) Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157: 919-926.
119. Adelmann M et al. (1995) The N-terminal domain of myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63: 17-27.
120. Kerlero de Rosbo N et al. (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27: 3059-3069.
121. Genain CP et al. (1995) Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 96: 2966-2974.
122. Xiao BG, Linington C, Link H. (1991) Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31: 91-96.
123. Sprinkle TJ. (1989) 2′3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-schwann cell and myelin-associated enzyme of the nervous system. CRC Crit Rev Neurobiol 4: 235-301.
124. Tsukada Y, Kurihara T. (1992) 2′-3′-Cyclic nucleotide 3′-phosphodiesterase: Molecular characterization and possible functional significance. In: Martenson (ed). Myelin: Biology and Chemistry. CRC Press: Boca Raton, Florida: pp 449-480.
125. Braun PE, Barnbrick LL, Edwards AM, Bernier L. (1990) 2′,3′-cyclic nucleotide 3′-phosphodiestorase has characteristics of cytoskeletal proteins. A hypothesis for its function. Ann NY Acad Sci 605: 55-65.
126. Birnbaum G et al. (1996) Heat shock protein and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2′,3′cyclic nucleotide 3′phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE. J Neurosci Res 44: 381-396.
127. Rösener M et al. (1997) 2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases. J Neuroimmunol 75: 28-34.
128. Mayes P. (1993) The pentose phosphate pathway and other pathways of hexose metabolism. In: Murray R, Granner D, Mayes P, Rodwell V (eds). Harper's Biochemistry. Appleton&Lange: Norwalk, Connecticut: pp 201-211.
129. Banki K et al. (1994) Oligodendrocyte-specific expression and autoantigenicity of transaldolase in Multiple Sclerosis. J Exp Med 180: 1649-1663.
130. Jacobson S. (1963) Sequence of myelination in the brain of the albino rat. J Comp Neurol 121: 5-29.
131. Colombo E et al. (1997) Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 99: 1238-1250.
132. Banki K, Halladay D, Perl A. (1994) Cloning and expression of the human gene for transaldolase: a novel highly repetitive element constitutes an integral part of the coding sequence. J Biol Chem 269: 2847-2851.
133. Zimmer DB, Cornwall EH, Landar A, Song W. (1995) The S100 protein family: History, Function, and Expression. Brain Res Bulletin 37: 417-429.
134. Bamford CR, Granley JP, Sibley WA, Laguna JM. (1978) Uveitis, perivascular sheathing and multiple sclerosis. Neurology 28 (suppl.2): 119-124.
135. Lightman S et al. (1987) Retinal venous sheathing in optic neuritis. Brain 110: 405-414.
136. Shaw PJ, Smith NM, Inca PG, Bates D. (1987) Chronic periphlebitis retinae in multiple sclerosis. J Neurol Sci 77: 147-152.
137. DeLibero G et al. (1991) Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma-delta T cells. J Exp Med 173: 1311-1322.
138. Parker CM et al. (1990) Evidence for extrathymic changes in the T cell receptor γδ repertoire. J Exp Med 171: 1597-1612.
139. Janis E, Kaufman S, Schwartz R, Pardoll D. (1989) Activation of γδ T cells in the primary immune response to mycobacterium tuberculosis. Science 244: 713-716.
140. Kabelitz D et al. (1991) The primary response of human γδ+ T cells to mycobacterium tuberculosis is restricted to Vγ9 bearing cells. J Exp Med 173: 1331-1338.
141. Birnbaum G. (1995) Stress proteins: their role in the normal central nervous system and in disease states, especially multiple sclerosis. Springer Semin Immunopathol 17: 107-118.
142. Haas W, Pereira P, Tonegawa S. (1993) Gamma/delta T cells. Annu Rev Immunol 11: 637-685.
143. Selmaj K, Brosnan CF, Raine CS. (1992) Expression of heat shock protein hsp65 by oligodendrocytes in vivo and in vitro: implications for Multiple Sclerosis. Neurology 42: 795-800.
144. Selmaj K, Brosnan CF, Raine CS. (1991) Colocalization of lymphocytes bearing gamma-delta T cell receptor and heat shock protein hsp65+ oligodendrocytes in Multiple Sclerosis. Proc Natl Acad Sci 88: 6452-6456.
145. Stinissen P et al. (1995) Increased frequency of γδ T cells in cerebrospinal fluid and peripheral blood of patients with Multiple Sclerosis. J Immunol 154: 4883-4894.
146. Battistini L et al. (1995) γδ T cell receptor analysis supports a role for HSP 70 selection of lymphocytes in Multiple Sclerosis lesions. Mol Med 1: 554-562.
147. Shimonkevitz R et al. (1993) Clonal expansion of activated γδ T cells in recent-onset multiple sclerosis. Proc Natl Acad Sci 90: 923-927.
148. Battistini L et al. (1995) Multiple Sclerosis: limited diversity of the Vδ2-Jδ3 T-cell receptor in chronic active lesions. Ann Neurol 37: 198-203.
149. Wucherpfennig K et al. (1992) γδ T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci 89: 4588-4592.
150. Freedman M, Ruijs T, Selin L, Antel J. (1991) Peripheral blood γδ T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol 30: 794-800.
151. Raine CS et al. (1996) Multiple Sclerosis: A protective or a pathogenetic role for heat shock protein 60 in the central nervous system? Lab Invest 75: 109-123.
152. Van Noort JM et al. (1995) The small heat shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375: 798-801.
153. Van Noort JM. (1996) Multiple sclerosis: an altered immune repsonse or an altered stress response? J Mol Med 74: 285-296.
154. Oldstone MB. (1987) Molecular mimicry and autoimmune disease. Cell 50: 819-820.
155. Fujinami RS, Oldstone MB. (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230: 1043-1045.
156. Jahnke U, Fischer EH, Alvord EC. (1985) Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 299: 282-284.
157. Liebert UG, Hashim GA, ter Meulen V. (1990) Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats. J Neuroimmunol 29: 139-147.
158. Jacobson S et al. (1984) Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 133: 754-757.
159. Jacobson S, Flerlage ML, McFarland HF. (1985) Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis. J Exp Med 162: 839-850.
160. Pette M et al. (1993) Measles virus-directed responses of CD4+ T lymphocytes in MS patients and healthy individuals. Neurology 43: 2019-2025.
161. Talbot PJ et al. (1996) Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 39: 233-240.
162. Wucherpfennig KW, Strominger JL. (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
163. Hemmer B et al. (1997) Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 185: 1651-1659.